Retour
27
Également cotée sous
CHEOY
OTC
Fourchette du Jour
116,81 €
116,81 €
Fourchette 52 Semaines
116,81 €
207,71 €
Volume
6 995
Moyenne 50J / 200J
181,02 €
/
185,43 €
Clôture Précédente
123,96 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,6 | 0,2 |
| P/B | 3,9 | 3,0 |
| ROE % | 20,5 | 3,6 |
| Net Margin % | 16,6 | 3,8 |
| Rev Growth 5Y % | 11,8 | 9,9 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
11,53 €
10,93 € – 12,27 €
|
2,52B | 1 |
| FY2029 |
10,69 €
10,14 € – 11,38 €
|
3,72B | 1 |
| FY2028 |
8,50 €
8,06 € – 9,05 €
|
3,16B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | 3,10 € | 1,64 € | -47,1% |
| 2025-08-13 | 1,94 € | 1,83 € | -5,7% |
| 2025-02-13 | 1,92 € | 1,93 € | +0,5% |
| 2024-08-15 | 2,07 € | 1,68 € | -18,8% |
| 2024-02-18 | 1,95 € | 1,98 € | +1,5% |
| 2023-06-30 | 1,63 € | 1,60 € | -1,8% |
| 2022-12-31 | 1,44 € | 1,47 € | +2,1% |
| 2022-06-30 | 1,26 € | 1,25 € | -0,8% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,72%
Growth (3Y)
9,55%
Growth (5Y)
23,86%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 20, 2026 | Apr 13, 2026 | 1,52 € | 2,37% |
| Sep 19, 2025 | Oct 13, 2025 | 1,42 € | 1,38% |
| Mar 21, 2025 | Apr 14, 2025 | 1,35 € | 1,72% |
| Sep 18, 2024 | Oct 10, 2024 | 1,42 € | 1,45% |
| Mar 21, 2024 | Apr 15, 2024 | 1,31 € | 1,09% |
| Sep 18, 2023 | Oct 11, 2023 | 1,13 € | 1,28% |
| Mar 21, 2023 | Apr 14, 2023 | 1,03 € | 1,30% |
| Sep 21, 2022 | Oct 17, 2022 | 0,94 € | 1,47% |
| Mar 28, 2022 | Apr 21, 2022 | 1,16 € | 1,30% |
| Sep 23, 2021 | Oct 18, 2021 | 1,02 € | 1,11% |
| Mar 25, 2021 | Apr 20, 2021 | 0,87 € | 0,55% |
| Mar 24, 2020 | Apr 17, 2020 | 0,95 € | 2,25% |
| Sep 19, 2019 | Oct 14, 2019 | 1,19 € | 1,50% |
| Mar 25, 2019 | Apr 16, 2019 | 1,10 € | 1,83% |
| Sep 17, 2018 | Oct 10, 2018 | 1,15 € | 1,54% |
| Mar 19, 2018 | Apr 12, 2018 | 1,08 € | 1,51% |
| Sep 19, 2017 | Oct 11, 2017 | 1,12 € | 1,65% |
| Mar 15, 2017 | Apr 06, 2017 | 0,99 € | 1,94% |
| Sep 07, 2016 | Sep 29, 2016 | 0,92 € | 1,61% |
| Mar 10, 2016 | Apr 01, 2016 | 0,82 € | 2,00% |
Points Clés
Revenue grew 11,84% annually over 5 years — strong growth
ROE of 20,52% indicates high profitability
Net margin of 16,60% shows strong profitability
Debt/Equity of 0,12 — conservative balance sheet
Generating 135,00M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,03%
Croissance
Revenue Growth (5Y)
11,84%
Revenue (1Y)4,81%
Earnings (1Y)9,00%
FCF Growth (3Y)-28,83%
Qualité
Return on Equity
20,52%
ROIC13,93%
Net Margin16,60%
Op. Margin17,33%
Sécurité
Debt / Equity
0,12
Current Ratio2,35
Interest Coverage36,92
Valorisation
P/E Ratio
19,64
Forward P/E17,24
P/B Ratio3,92
EV/EBITDA18,71
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,81% | Revenue Growth (3Y) | 10,01% |
| Earnings Growth (1Y) | 9,00% | Earnings Growth (3Y) | 13,74% |
| Revenue Growth (5Y) | 11,84% | Earnings Growth (5Y) | 4,47% |
| Profitability | |||
| Revenue (TTM) | 2,34B | Net Income (TTM) | 388,90M |
| ROE | 20,52% | ROA | 13,77% |
| Gross Margin | 73,74% | Operating Margin | 17,33% |
| Net Margin | 16,60% | Free Cash Flow (TTM) | 135,00M |
| ROIC | 13,93% | FCF Growth (3Y) | -28,83% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,35 |
| Interest Coverage | 36,92 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,72% |
| Dividend Growth (3Y) | 9,55% | Dividend Growth (5Y) | 23,86% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 19,64 | Forward P/E | 17,24 |
| P/B Ratio | 3,92 | P/S Ratio | 3,26 |
| PEG Ratio | 5,17 | Forward PEG | N/A |
| EV/EBITDA | 18,71 | Fwd EV/EBITDA | 10,48 |
| Forward P/S | 2,88 | Fwd Earnings Yield | 5,80% |
| FCF Yield | 1,77% | ||
| Market Cap | 7,64B | Enterprise Value | 7,60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,34B | 2,24B | 1,94B | 1,65B | 1,50B |
| Net Income | 388,90M | 356,80M | 300,60M | 289,10M | 326,50M |
| EPS (Diluted) | 5,93 | 5,43 | 4,56 | 4,40 | 4,93 |
| Gross Profit | 1,73B | 1,67B | 1,45B | 1,24B | 1,09B |
| Operating Income | 406,10M | 475,00M | 389,50M | 402,40M | 370,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,83B | 2,75B | 2,57B | 2,47B | 2,44B |
| Total Liabilities | 874,70M | 904,60M | 819,90M | 779,40M | 736,50M |
| Shareholders' Equity | 1,95B | 1,84B | 1,75B | 1,69B | 1,70B |
| Total Debt | 235,70M | 243,70M | 201,80M | 253,90M | 264,30M |
| Cash & Equivalents | 275,70M | 513,60M | 555,50M | 629,30M | 609,60M |
| Current Assets | 1,42B | 1,45B | 1,36B | 1,33B | 1,23B |
| Current Liabilities | 602,30M | 631,50M | 578,00M | 527,60M | 402,50M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#161 of 203
Activité Récente
Entré
Value Investing (Warren Buffett)
Mar 24, 2026